CpG Oligonucleotides as Cancer Vaccine Adjuvants

Vaccines
Hidekazu ShirotaDennis M Klinman

Abstract

Adjuvants improve host responsiveness to co-delivered vaccines through a variety of mechanisms. Agents that trigger cells expressing Toll-like receptors (TLR) activate an innate immune response that enhances the induction of vaccine-specific immunity. When administered in combination with vaccines designed to prevent or slow tumor growth, TLR agonists have significantly improved the generation of cytotoxic T lymphocytes. Unfortunately, vaccines containing TLR agonists have rarely been able to eliminate large established tumors when administered systemically. To improve efficacy, attention has focused on delivering TLR agonists intra-tumorally with the intent of altering the tumor microenvironment. Agonists targeting TLRs 7/8 or 9 can reduce the frequency of Tregs while causing immunosuppressive MDSC in the tumor bed to differentiate into tumoricidal macrophages thereby enhancing tumor elimination. This work reviews pre-clinical and clinical studies concerning the utility of TLR 7/8/9 agonists as adjuvants for tumor vaccines.

References

Mar 5, 1998·Journal of the American Academy of Dermatology·K R BeutnerJ M Douglas
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G HartmannA M Krieg
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H ShirotaK Shirato
Dec 29, 2000·Nature·H HemmiS Akira
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D VerthelyiD M Klinman
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·I GurselD M Klinman
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y KawaradaG J Hämmerling
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Veit HornungGunther Hartmann
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sander ZwavelingCornelis J M Melief
Sep 5, 2002·European Journal of Immunology·Tobias MaurerHermann Wagner
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Klaus HeckelsmillerGunther Hartmann
Dec 5, 2002·Clinical and Experimental Dermatology·M A Stanley
Dec 14, 2002·Human Immunology·Hubertus HochreinHermann Wagner
Jan 31, 2003·European Journal of Immunology·Klaus HeckelsmillerGunther Hartmann
Feb 12, 2004·Cancer Research·Qingsheng LiShu-Hsia Chen
Feb 19, 2004·European Journal of Immunology·Jörg VollmerArthur M Krieg
Apr 2, 2004·Nature Reviews. Immunology·Dennis M Klinman
May 19, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·George K MutwiriLorne A Babiuk
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fumihiko TakeshitaKen J Ishii
Sep 30, 2004·Nature Immunology·Akiko Iwasaki, Ruslan Medzhitov
Nov 19, 2004·Nature Immunology·Marco ColonnaYong-Jun Liu
Jan 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keith B GordenJohn P Vasilakos
Feb 8, 2005·The Journal of Clinical Investigation·Daniel E SpeiserPedro Romero
Aug 2, 2005·Nature Reviews. Immunology·Vincenzo Bronte, Paola Zanovello

❮ Previous
Next ❯

Citations

Dec 29, 2016·Journal of Biomedical Materials Research. Part a·Ahmed El-HusseinMichael R Hamblin
Dec 8, 2017·Journal of Cellular Physiology·Parvin ZamaniAmirhossein Sahebkar
Oct 5, 2018·Annual Review of Pharmacology and Toxicology·C I Edvard Smith, Rula Zain
Jan 15, 2019·Biomaterials Science·Kewen Lei, Li Tang
Apr 23, 2019·Expert Review of Vaccines·Indranil SarkarSylvia van Drunen Littel-van den Hurk
Oct 7, 2017·Current Medicinal Chemistry·Giulia FreerMauro Pistello
Jan 2, 2016·Pharmacological Reviews·Styliani GoulopoulouR Clinton Webb
Apr 23, 2017·Journal of Cancer Research and Clinical Oncology·Mariela A Moreno AyalaMarianela Candolfi
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Priscilla S BriquezJeffrey A Hubbell
Jul 25, 2017·Cancer Immunology, Immunotherapy : CII·Shuku-Ei ItoChikashi Ishioka
Mar 14, 2019·Frontiers in Immunology·Natalia K BotelhoPedro Romero
Feb 23, 2020·Frontiers in Immunology·Dilraj KaurGajendra P S Raghava
May 11, 2020·Cancer Immunology, Immunotherapy : CII·Adele M BarrAdriana Baz Morelli
Sep 13, 2020·Cells·Simone HagerMatthias Bros
Jul 1, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Chintan H KapadiaEmily S Day
Feb 12, 2019·Frontiers in Immunology·Apriliana E R KartikasariMagdalena Plebanski
Aug 1, 2020·Frontiers in Immunology·Lei QinBin Zhang
Jul 1, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Katarzyna Sawa-Wejksza, Martyna Kandefer-Szerszeń
Aug 2, 2017·Macromolecular Bioscience·Benjamin WeberMatthias Barz
Aug 18, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Adam Yuh LinLeo I Gordon
Mar 5, 2021·Vavilovskiĭ Zhurnal Genetiki I Selekt︠s︡ii·A A OstaninE R Chernykh
May 27, 2021·Biomaterials Science·Qiushuang ZhangChuan Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.